Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors
Clinical trial NCT04860076 · UNKNOWN
Trial details
- NCT number
- NCT04860076
- Sponsor
- Asylia Diagnostics BV
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-06
- Primary completion
- 2022-06-06
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.